Generative Biology

Generative biology is Amy Webb’s biology-and-chemistry branch of AI Convergence in How convergence will define the tech sector in 2026. She compares it to generative AI: data goes in, and a new molecule or genome can come out.

The episode names EVO2 as a research project in this direction and compares the emerging workflow to Vibe Coding in biology. The source’s wiki value is as a bridge between the existing AI For Science and AI Drug Discovery Platform pages and a broader claim that biological design may become more programmable.

Key Claims

• Generative biology treats molecules, genomes, or related biological artifacts as outputs that models can help design.
• The source frames the field as an extension of generative AI into biology and chemistry, not as a proven replacement for wet-lab validation.
• The concept depends on verification: generated biological candidates still need experimental evidence, safety review, and usable deployment pathways.
• The analogy to vibe coding is useful as an interface claim, but it should not erase the higher stakes and slower feedback loops of biological systems.

Connections

• EVO2 - research project named by the source.
• AI For Science and Scientific Discovery Automation - broader scientific-discovery context.
• AI Drug Discovery Platform and AI Protein Design - adjacent biology and drug-discovery branches.
• Programmable Matter - neighboring programmable-design branch in materials.
• AI Convergence - umbrella frame from the Marketplace Tech episode.